Endurant Capital Management LP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$4,693,886
+40.5%
217,209
+25.8%
1.91%
+75.2%
Q3 2022$3,342,000
+345.0%
172,621
+356.2%
1.09%
+313.7%
Q2 2022$751,000
-79.2%
37,835
-68.7%
0.26%
-72.3%
Q1 2022$3,604,000
+135.7%
120,834
+84.1%
0.95%
+157.2%
Q4 2021$1,529,000
-58.2%
65,638
-44.1%
0.37%
-55.8%
Q3 2021$3,661,000
+0.5%
117,328
+13.3%
0.83%
-16.7%
Q2 2021$3,642,000
+0.1%
103,512
+0.3%
1.00%
+5.6%
Q1 2021$3,637,000
+129.3%
103,175
+144.0%
0.95%
+65.7%
Q4 2020$1,586,000
-8.9%
42,292
-18.9%
0.57%
+11.1%
Q3 2020$1,740,00052,1310.52%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 1,704,330$60,504,0001.59%
Birchview Capital, LP 38,000$1,349,0000.92%
Virtus ETF Advisers LLC 24,688$876,0000.77%
BVF INC/IL 220,000$7,810,0000.76%
SECTORAL ASSET MANAGEMENT INC 172,803$6,135,0000.69%
Chicago Capital, LLC 134,748$4,784,0000.39%
Artal Group S.A. 500,000$17,750,0000.38%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$25,432,0000.33%
Eversept Partners, LP 18,029$640,0300.29%
HEARTLAND ADVISORS INC 125,000$4,438,0000.29%
View complete list of ALBIREO PHARMA INC shareholders